SCHEMBL13715298

SCHEMBL13715298

Oc1cccc2c1c1ccccc1n2-c1ccc2sc3ccc(-n4c5ccccc5c5c(O)cccc54)cc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ MAPT P10636 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALOX5 P09917 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ APP P05067 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ SNCA P37840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18086141 0.84 GPR3 (0.44) MAOAMAOBMAPTKDM4EATM
SCHEMBL13715325 0.83 KDM4E (0.48) MAOAMAPTHTTKDM4EATM
SCHEMBL30692086 0.83 KDM4E (0.48) MAOAMAPTHTTKDM4EATM
SCHEMBL29397828 0.83 KDM4E (0.52) MAOAMAOBMAPTKDM4EATM
SCHEMBL29398379 0.83 KDM4E (0.52) MAOAMAOBMAPTKDM4EATM
SCHEMBL126273 0.83 KDM4E (0.52) MAOAMAOBMAPTKDM4EATM
SCHEMBL15275604 0.83 KDM4E (0.40) MAOAMAOBKDM4EATML3MBTL1
SCHEMBL20706657 0.83 GPR3 (0.40) MAOAMAOBMAPTKDM4EATM
SCHEMBL12926106 0.83 KDM4E (0.40) MAOAMAOBKDM4EATML3MBTL1
SCHEMBL16484421 0.82 KDM4E (0.39) MAPTKDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090206327-A1 ORGANOMETALLIC COMPLEXES SLC25A11, TIMM9, TIMM50 MAOA 4023/4885MAOB 4280/4885MAPT 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback